Log in to search using one of your social media accounts:

 

AmalgamRX to launch stress reduction app for patients with psoriasis, psoriatic arthritis
Digital therapy platform AmalgamRX has just announced the upcoming launch of its new app, Beyond, which aims to help patients living with psoriasis and psoriatic arthritis providing them resources to manage stress. (Source: mobihealthnews)
Source: mobihealthnews - December 13, 2017 Category: Information Technology Source Type: news

New GRAPPA and EULAR Recommendations for Managing PsA New GRAPPA and EULAR Recommendations for Managing PsA
GRAPPA and EULAR have provide updated recommendations regarding the management and treatment of psoriatic arthritis.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 12, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

BAD Guidelines for Biologic Therapy for Psoriasis 2017 BAD Guidelines for Biologic Therapy for Psoriasis 2017
The British Association of Dermatologists provides evidence-based recommendations on the use of biologic therapies for the treatment of psoriasis and psoriatic arthritis in adults and children.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 12, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis
Psoriatic arthritis is the second approved indication for Taltz in the United States. (Source: ConsultantLive)
Source: ConsultantLive - December 12, 2017 Category: Internal Medicine Authors: Rheumatology Network Staff Tags: Psoriatic Arthritis Source Type: news

Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis
Psoriatic arthritis is the second approved indication for Taltz in the United States. (Source: CancerNetwork)
Source: CancerNetwork - December 12, 2017 Category: Cancer & Oncology Authors: Rheumatology Network Staff Tags: Psoriatic Arthritis Source Type: news

Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis Ixekizumab Gets FDA Nod for Active Psoriatic Arthritis
Ixekizumab significantly improves symptoms of psoriatic arthritis in patients naive to prior biologic therapy and in patients who had failed prior to biologic therapy.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 6, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Lilly's Taltz (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis
INDIANAPOLIS, Dec. 1, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Taltz (ixekizumab) injection 80 mg/mL for the treatment of adults with active psoriatic... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 1, 2017 Category: Drugs & Pharmacology Source Type: news

Bariatric Tx Tied to Lower Psoriasis Risk in Obese Patients (CME/CE)
(MedPage Today) -- Benefit did not extend to psoriatic arthritis (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 27, 2017 Category: Dermatology Source Type: news

Tofacitinib is Effective in Psoriatic Arthritis
This agent was superior to placebo in patients who had not responded to or could not take a conventional DMARD. (Source: CancerNetwork)
Source: CancerNetwork - November 21, 2017 Category: Cancer & Oncology Authors: Gregory M. Weiss, M.D. Tags: Psoriatic Arthritis Source Type: news

Tofacitinib is Effective in Psoriatic Arthritis
This agent was superior to placebo in patients who had not responded to or could not take a conventional DMARD. (Source: ConsultantLive)
Source: ConsultantLive - November 21, 2017 Category: Internal Medicine Authors: Gregory M. Weiss, M.D. Tags: Psoriatic Arthritis Source Type: news

Subcutaneous Secukinumab Relieves Psoriatic Arthritis Subcutaneous Secukinumab Relieves Psoriatic Arthritis
The interleukin-17A inhibitor is effective and safe, according to first results from the ongoing FUTURE5 study, the largest controlled trial of a biologic for psoriatic arthritis to date.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Long-Term Use of Lilly's Taltz(R) (ixekizumab) Shows Efficacy Improvements in Psoriatic Arthritis for Patients with Prior Inadequate Response or Intolerance to TNF Inhibitors
Taltz also demonstrated improvements in key secondary measures, including skin clearance, at 52 weeks INDIANAPOLIS, Nov. 8, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today patients with active psoria... Biopharmaceuticals Eli Lilly, Taltz, ixekizumab, Psoriatic Arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2017 Category: Pharmaceuticals Source Type: news

New phase 2 data show treatment with tremfya ® (guselkumab) improved psoriatic arthritis symptoms through one year
Longer-Term Results Demonstrate Continued Efficacy of Anti-Interleukin 23 Monoclonal Antibody TREMFYA ® in Improving Joint and Skin Symptoms Associated with Active Psoriatic Arthritis (Source: Johnson and Johnson)
Source: Johnson and Johnson - November 7, 2017 Category: Pharmaceuticals Source Type: news

Golimumab Gets FDA Nod for Two New Indications Golimumab Gets FDA Nod for Two New Indications
The TNF-alpha inhibitor significantly improved the signs and symptoms of psoriatic arthritis and ankylosing spondylitis in phase 3 testing.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Janssen receives two u.s. fda approvals for simponi aria ® (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis
SIMPONI ARIA ® is the Only Fully-Human Anti-TNF-alpha Infused Therapy Now Approved for Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis (Source: Johnson and Johnson)
Source: Johnson and Johnson - October 21, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves Simponi Aria (golimumab) for the Treatment of Adults With Active Psoriatic Arthritis or Active Ankylosing Spondylitis
Horsham, Pa., October 20, 2017 ― Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved Simponi Aria (golimumab), the only fully-human anti-tumor necrosis factor (TNF)-alpha therapy administered via a... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 20, 2017 Category: Drugs & Pharmacology Source Type: news

Tofacitinib Shows Promise in Psoriatic Arthritis Tofacitinib Shows Promise in Psoriatic Arthritis
Tofacitinib is better than placebo for psoriatic arthritis that has responded poorly to treatment with conventional disease-modifying antirheumatic drugs and tumor necrosis factor inhibitors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 18, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Magnetic Resonance Imaging in Psoriatic Arthritis Magnetic Resonance Imaging in Psoriatic Arthritis
A new study explores the important role axial and peripheral MRI scans can play in the evaluation and management of patients with psoriatic arthritis.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 16, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

What Are the Different Types of Psoriatic Arthritis?
Title: What Are the Different Types of Psoriatic Arthritis?Category: Doctor's& Expert's views on SymptomsCreated: 10/2/2017 12:00:00 AMLast Editorial Review: 10/2/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - October 2, 2017 Category: Rheumatology Source Type: news

Sonographic Enthesitis and Radiographic Damage in PsA Sonographic Enthesitis and Radiographic Damage in PsA
Is the severity of sonographic enthesitis a predictor of joint damage in psoriatic arthritis patients?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 27, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Education, Screening for Psoriatic Arthritis Key in Psoriasis Education, Screening for Psoriatic Arthritis Key in Psoriasis
A new study compares screening methods for psoriatic arthritis, underscoring the importance of incorporating patient education and screening of PsA into clinical assessment of patients with psoriasis.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 31, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Secukinumab for Psoriasis and Psoriatic Arthritis Secukinumab for Psoriasis and Psoriatic Arthritis
This article reviews phase II and phase III clinical trials for secukinumab, an IL-17A inhibitor which presents a promising new treatment approach for refractory psoriasis and psoriatic arthritis.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 15, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

FDA Advisory Committee votes in favor of XELJANZ ® (tofacitinib citrate) for the treatment of active psoriatic arthritis
Pfizer Inc. announced that the United States Food and Drug Administration's (FDA) Arthritis Advisory Committee (AAC) voted 10 to 1 to recommend approval of the proposed dose of tofacitinib for the treatment of adult patients with active psoriatic arthritis (PsA). Pfizer submitted supplemental new drug applications (sNDAs) for XELJANZ® 5 mg twice daily (BID) and XELJANZ® XR extended release 11 mg once daily (QD) for this pending indication. (Source: World Pharma News)
Source: World Pharma News - August 4, 2017 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

FDA approves Bristol-Myers Squibb ’s Orencia for active psoriatic arthritis
The US Food and Drug Administration (FDA) has approved Bristol-Myers Squibb ’s Orencia for the treatment of adult patients with active psoriatic arthritis (PsA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 9, 2017 Category: Pharmaceuticals Source Type: news

Bristol-Myers Squibb ’s Orencia (abatacept) Receives FDA Approval for Treatment of Active Psoriatic Arthritis in Adults
PRINCETON, N.J.--(BUSINESS WIRE) July 6, 2017 --Bristol-Myers Squibb Company (NYSE:BMY) announced today the U.S. Food and Drug Administration (FDA) has approved Orencia for the treatment of adults with active Psoriatic Arthritis (PsA)1, a chronic2,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 6, 2017 Category: Drugs & Pharmacology Source Type: news

Psoriatic Arthritis Often Remits During Pregnancy (CME/CE)
(MedPage Today) -- Arthritis trends favorably; psoriasis improves or remains stable (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - July 5, 2017 Category: Dermatology Source Type: news

Novartis gets European OK for biosimilar of Amgen's Enbrel
ZURICH (Reuters) - Novartis's generics unit Sandoz said the European Commission approved Erelzi, its biosimilar to Amgen's Enbrel, to treat inflammatory diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis. (Source: Reuters: Health)
Source: Reuters: Health - June 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Targeting IL-23 a Hit in Psoriatic Arthritis (CME/CE)
(MedPage Today) -- Multiple disease domains showed significant improvement (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - June 19, 2017 Category: General Medicine Source Type: news

EULAR 2017: Lilly's Taltz(R) (ixekizumab) Demonstrated No Progression or Minimal Progression of Radiographic Disease in Patients with Psoriatic Arthritis Through 52 Weeks
INDIANAPOLIS, June 16, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that the majority of patients with active psoriatic arthritis (PsA) treated with Taltz® (ixekizumab) exhibited either no progres... Biopharmaceuticals Eli Lilly, Taltz, ixekizumab, psoriatic arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2017 Category: Pharmaceuticals Source Type: news

New effective treatments for psoriatic arthritis patients
(European League Against Rheumatism) The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference revealed promising data supporting two new drug classes for the treatment of psoriatic arthritis (PsA). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2017 Category: International Medicine & Public Health Source Type: news

New Phase 3 Data Show Anti-TNF Alpha SIMPONI ARIA ® (golimumab) Significantly Improved Arthritis And Skin Manifestations In Patients With Active Psoriatic Arthritis
Treatment with SIMPONI ARIA ® Showed Significant Inhibition in the Progression of Structural Damage (Source: Johnson and Johnson)
Source: Johnson and Johnson - June 14, 2017 Category: Pharmaceuticals Source Type: news

Ixekizumab Eases Psoriatic Arthritis When TNF Inhibitor Fails Ixekizumab Eases Psoriatic Arthritis When TNF Inhibitor Fails
The selective interleukin-17A inhibitor ixekizumab improved signs and symptoms of active psoriatic arthritis (PsA) in patients who had failed prior biologic therapy in the phase 3 SPIRIT-P2 trial.Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 2, 2017 Category: Dermatology Tags: Dermatology News Source Type: news

Identifying Preclinical Psoriatic Arthritis in Hope of Prevention Identifying Preclinical Psoriatic Arthritis in Hope of Prevention
Dr Kevin Deane explains how this new research may provide a window of opportunity for preventing psoriatic arthritis.Medscape Rheumatology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - May 31, 2017 Category: Pathology Tags: Rheumatology Viewpoint Source Type: news

Arthritis news: Drug could treat condition linked to psoriasis
PSORIATIC arthritis is linked to the skin condition psoriasis and is often painful, but a new drug could help significantly relieve symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - May 30, 2017 Category: Consumer Health News Source Type: news

Promising Results for Drug for Psoriatic Arthritis
Psoriatic arthritis causes painful joint swelling, but new medication Taltz might help (Source: WebMD Health)
Source: WebMD Health - May 26, 2017 Category: Consumer Health News Source Type: news

Promising Results for Drug to Fight Arthritis Linked to Psoriasis
Psoriatic arthritis causes painful joint swelling, but new medication Taltz might help Source: HealthDay Related MedlinePlus Pages: Medicines, Psoriatic Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 26, 2017 Category: Consumer Health News Source Type: news

Promising Results for Ixekizumab Against Psoriatic Arthritis
FRIDAY, May 26, 2017 -- A new drug might help ease the pain and disability of a form of arthritis often linked to psoriasis. According to Stanford University researchers, psoriatic arthritis is an inflammatory joint disorder tied to an... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 26, 2017 Category: General Medicine Source Type: news

CME Outfitters Releases Preliminary Outcomes Findings from Psoriatic...
CMEO preliminary results show symposium on psoriatic arthritis featuring patient voice improved knowledge, behavior, and confidence among clinicians(PRWeb May 26, 2017)Read the full story at http://www.prweb.com/releases/2017/05/prweb14373069.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 26, 2017 Category: Pharmaceuticals Source Type: news

Denmark Sees Trend of Rising Psoriatic Arthritis (CME/CE)
(MedPage Today) -- One possible reason: increased attention from patients and docs (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - May 18, 2017 Category: Rheumatology Source Type: news

Minimal Disease Activity and Impact of Disease in PsA Minimal Disease Activity and Impact of Disease in PsA
What is the association between minimal disease activity and the impact of psoriatic arthritis?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Abatacept Helps Joints in Psoriatic Arthritis (CME/CE)
(MedPage Today) -- Benefits were less for skin manifestations (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 7, 2017 Category: Dermatology Source Type: news

Medical News Today: Diet tips for psoriatic arthritis: Foods to eat and avoid
In this article, learn about the foods to eat for people with psoriatic arthritis. Also find how to maintain a healthy gut including the use of probiotics. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 18, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Psoriatic arthritis and fatigue: Treatment, coping, and management
People with psoriatic arthritis may experience fatigue due to inflammation and chronic pain. In this article, learn about how to manage this tiredness. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Ten natural treatments for psoriatic arthritis
In this article, learn about ten natural remedies for psoriatic arthritis, what alternative therapies may be recommended, and the best diet for PsA. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

I’m 33, But My Autoimmune Disease Makes My Body Feel Like I’m 70
As told to Carina Storrs Jennifer Pellegrin, 33, found out she had psoriatic arthritis at a doctor’s visit for an unrelated procedure. At first, she did not think much of the diagnosis or fully understand how it would change her life. But seeing family members cope with the disease opened her eyes to its devastating effects. Now, she finds strength by helping others and credits the autoimmune disease for helping her become the person she is today. At first, being diagnosed with psoriatic arthritis didn’t seem so bad. But that just shows how little I knew about the disease back then. My primary care doctor decid...
Source: Healthy Living - The Huffington Post - April 11, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Psoriatic arthritis: Pictures of symptoms and progression
In this article, we look at the different stages and symptoms of psoriatic arthritis, a chronic condition which may worsen over time. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 11, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Causes of psoriatic arthritis: Triggers and risk factors
Learn about the common triggers for symptoms of psoriatic arthritis, including stress, smoking, and cold weather. What role does family history play? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 9, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Prognosis of psoriatic arthritis: Progression and outlook
In this article, learn how psoriatic arthritis may progress, the quality of life to be expected, and what treatment options are available. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 9, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Medical News Today: Psoriatic arthritis radiology: Imaging tests for diagnosis
What is psoriatic arthritis and what types of radiology may be used to make a diagnosis? What other tests may be available and who should get checked? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 8, 2017 Category: Consumer Health News Tags: Eczema / Psoriasis Source Type: news

Galapagos starts dosing in EQUATOR trial of filgotinib to treat psoriatic arthritis
Biotechnology firm Galapagos has started dosing patients in its Phase II EQUATOR clinical trial of filgotinib for the treatment of moderately to severely active psoriatic arthritis. (Source: Drug Development Technology)
Source: Drug Development Technology - April 5, 2017 Category: Pharmaceuticals Source Type: news